chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 7 minutes after administration of vaccine, patient reports having tingling sensation on head and face.  Symptoms lasted for approximately 10 minutes.  Blood pressure @4:34pm was 140/87, HR=71.  Blood pressure @16:52 was 150/73, HR=105.  At 5:10pm, patient clinically stable.  Symptoms have completely resolved.  Patient released from vaccination clinic at 5:14pm.
Pt. developed progressive myalgias after ZOSTAVAX vaccine. Rheumatology consulted and diagnosed polymyalgia rheumatica and referred to vascular surgery and had bilateral temporal artery biopsies for Giant Cell Arteritis. Pt. treated with prednisone started 5/19/15 and ending October 2016.
~24 hr after 2nd varicella imm. tender reddened area the size of a tennis ball.  In 48 hr increased redness, sl firm warm to touch.  72 hours later much improved.
This case was reported by a sales representative and described the occurrence of fever in a 48-year-old female subject (the reporter's sister) who was vaccinated with FLUARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject's medical history included mastectomy. Concurrent medical conditions included breast cancer and breast implant. There were no concurrent medications. On 6 February 2009 at 09:00 the subject received unspecified dose of FLUARIX in the left arm. Six hours after FLUARIX injection, the subject developed fever, swelling and redness. Severe muscle pain began at an unknown time and was described as getting worse. Also reported were swollen lymph nodes under her arms and around her back, severe headache, neck pain, fatigue, chest tightness and heaviness and she was not able to get out of bed for three days. The subject contacted the clinic 24 hours after experiencing the events and was told to see her oncologist. During a follow-up visit to the clinic on an unspecified date, she had a Strep test and bloodwork which were negative. A nasal swab for flu was also negative. On the morning of reporting, the subject reported a fever of 102.1 degrees. The subject contacted her husband and was waiting to be taken to the emergency room. At the time of reporting the outcome of the events was unspecified.
Member developed a rash, starting the evening after receiving the vaccine, first below his waist to his lower extremities,then to his upper torso the next morning. He reported having dizziness,eye irritation along with tongue tingling the following day, prompting a visit at a local walk in clinic. The member was treated with Benadryl which reportedly resolved his symptoms.
large red raised rash/welt; large red raised rash/welt; large red raised rash/welt; This is a spontaneous report from a contactable consumer (patient). A 27-year-old non-pregnant female patient received second dose of BNT162B2 (brand=Pfizer), lot number: EL9266, via an unspecified route of administration in the left arm on 16Feb2021 as single dose for COVID-19 immunisation. No relevant medical history. No covid prior vaccination. No known allergies. Concomitant medication included sodium chloride (MURO 128) eye ointment. The patient previously received first dose of BNT162B2 (brand=Pfizer) for COVID-19 immunisation on 21Jan2021 05:45 PM (lot number: EL3247). With the first vaccine, it was extremely painful and she was unable to move her arm for several days on 23Jan2021 12:00 AM. About 2 days after vaccine (18Feb2021), a large red raised rash/welt appeared on upper left arm. No treatment for the events. No covid test post vaccination. The patient recovered from all events on an unspecified date.   No follow-up attempts are possible. No further information is expected.
pt recv vax 2NOV94 & 08NOV94 pt devel SOB & a cough; pt was seen in ER by MD; CXR revealed segmented pneumonitis of the lateral & posterior segments of the lt lower lobe; lab eval on 02DEC94 revealed a nl CBC;
ZOSTAVAX administered 5/29/08.  Patient called c/o a systemic vesicular, itchy rash 6/4/08, rash first noted 6/3/08.
I started to experience left shoulder pain a few weeks after receiving my second dose of the Moderna vaccine.   I took ibuprofen and naproxen to try to relieve the pain, but it would only help for a few hours and then the pain would come back.  I also have been using heating pads to help with the pain.   I thought the pain might be from me sleeping on my side so I bought a new pillow for side sleepers.  It helps a little bit but through out the day the pain will come back.  Sometimes the pain radiates from my shoulder to my left clavicle. And sometimes it hurts so much that I cant lift my arm.  And only after elevating it and resting does the pain subside a little bit.  At first I thought it might be job stress related because I do work at a high volume pharmacy that i s administering the covid vaccines, but even when I am not at work it starts to hurt.
Arm pain, extreme fatigue, muscle spasm (charley horse) in left inner thigh, shin and foot.
12/16 2130. Presented to ED 12/16 with fever 104.8. Treated with TYLENOL and discharged to home. Returned to ED on 12/17-0615 - altered Mental Status, diarrhea, Rash, T 99.8 - Cardiac arrest - Intubation, code Meds, ROCEPHIN, Vancomycin, acyclovir. Transferred.  12/30/09 Preliminary autopsy report. DOD 12/17/09. Cause of Death: None provided. Additional information abstracted: Cerebrospinal fluid positive for gram negative diplococci on gram stain.  12/30/09 Preliminary autopsy report. DOD 12/17/09. Cause of Death: None provided. Additional information abstracted: Cerebrospinal fluid positive for gram negative diplococci on gram stain. \ksk  12/31/09 ED consultation records received. Service date 12/17/09. Assessment: Thrombocytopenia, purpuric rash, cardiopulmonary respiratory arrest, shock with septic and hypovolemic metabolic acidosis, hematemesis, screen for meningococcemia. Child presented to the ED the previous evening with a temperature of 104.8 F was medicated for fever and discharged. This AM presents with a purpuric rash all extremities. Diarrhea, lethargic. Decreased level of consciousness. Intubated and attempted to stabilize for air transport. Abdominal distention. Blood-tinged mucus fluid from nose and mouth. Full CPR. Pulseless electrical activity.
Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Numbness in left arm from elbow down x 14 days. Denies any other side effects such as pain, redness, swelling, warmth. Pt says he is also unable to fully extend the arm.
Hives following 3rd GARDASIL injection, resolving with BENADRYL and MEDROL Pak. Not reported until 1 month following injection.
she had localized pain on the injection site after receiving the 4 doses.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (she had localized pain on the injection site after receiving the 4 doses.) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient had no known allergies and no chronic illness at the time of vaccination.  Concomitant products included CANNABIDIOL (CBD OIL), SIMVASTATIN and FAMOTIDINE for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (she had localized pain on the injection site after receiving the 4 doses.). At the time of the report, VACCINATION SITE PAIN (she had localized pain on the injection site after receiving the 4 doses.) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2022-554212, MOD-2022-554220, MOD-2022-554223 (Patient Link).
I had just finished my menstural  bleeding two days before the shot.  I started bleeding  again after getting the vaccine. Breast tenderness.  Hearing loss on day 3 that went back to normal two days later, followed by the most excruciating headache  I have ever had that hasn?t subsided for 48 hours straight until I went to a migraine clinic. Relief now, 5 hours later., maintaining excederine doses and migraine medication when migraine headache returns.
Feeling anxious or nervous; Feeling anxious or nervous; Sometimes hard to speak; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Feeling anxious or nervous), NERVOUSNESS (Feeling anxious or nervous) and DYSARTHRIA (Sometimes hard to speak) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Feeling anxious or nervous), NERVOUSNESS (Feeling anxious or nervous) and DYSARTHRIA (Sometimes hard to speak). At the time of the report, ANXIETY (Feeling anxious or nervous), NERVOUSNESS (Feeling anxious or nervous) and DYSARTHRIA (Sometimes hard to speak) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive after Vaccination.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication reported by reporter.  No Treatment Medication reported by reporter.
Developed flat red non-itchy, non-indurated rash in upper torso. Developed 7-10 lestions after smallpox vaccination. Rash eventually resolved by itself.
Herpes simplex outbreak buttocks Increased  coughing, enough to keep me up at night Fever 100.5 for 24 hours Headache/body aches
Approximately 48 hours after shot was administered, skin around shot site became bright red, swollen, and inflamed. The reaction continued to grow to about the size of a large grapefruit.
32 Y male with PMHx of follicular lymphoma diagnosed 12/2018, s/p R-CHOP and 2 year maintenance rituxan recently completed 6/2021, and currently under annual surveillance. Received Moderna vaccine 4/4 and 5/2. Developed fever and cough on 9/8. Tested covid positive on 9/10. Presented with worsening SOB.    COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/8/21. COVID positive on 9/10/21. Last fever 9/18. Initially on decadron 6mg daily. Due to increased FiO2 requirement, increased to 10mg daily on 9/17 and switched to solumedrol 125 mg q6h on 9/21 and then 250 mg q6h on 9/22 when his FiO2 increased to 35 lpm and 60%. Started steroid taper on 9/25  and transitioned to decadron 10mg BID on  9/27-28). Then plan 6mg BID x 2 days then stop. FiO2 requirement continues to decrease, now down to 3 lpm. Received tocilizumab on 9/21 and 9/22. Hep panel, gamma interferon, cocci serology are negative. Completed remdesivir course (9/16 - 9/20).    Left cheek cellulitis - developed left cheek swelling than increased over several days. CT on 9/27 showed cellulitis. Reviewed with ENT, did not think there was an abscess. Started unasyn. WBC has increased but remains afebrile. Can consider re-imaging if not improving/develops fever.    Thrombocytopenia - mild, likely due to viral illness.  Resolved.    Constipation - resolved with miralax, prn lactulose and changing Robitussin AC to prn   Primary Procedures:  None   Secondary Procedures: None
Received Havrix #1 in left deltoid on 1/22/01. Noted urticaria at injection site and began scratching area, immediately after injection. At home, noted she had broken skin when scratching. Area of itchy, fine, red rash has since spread to entire left upper arm, from elbow to shoulder. No fever, but did come down with a head cold the next day. No respiratory distress.
pt recv vax 1JUN95 & 2APR97 pt devel chicken pox about 40 lesions;pt seen by MD 21APR97;dx of varicella was confirmed;
It was reported that an 18 month old female received vaccine on 11/2/99. Reportedly, on 11/3/99, between 07:00 and 08:00, the pt developed localized erythema and mild induration at injection site with bruising 7 1/2cm X 9cm, mild swelling and was warm to touch. Reportedly, this adverse reaction is presently resolving. Documentation received on 12/1/99, added that there were no labs performed and that the pt had recovered, at this time.
Narrative:  Patient passed away after trying to climb the stairs and falling. He was taken to the Emergency Department and ultimately passed away from a brain bleed.
After patient received the vaccine, she started to have seizures and passed out for abut a couple minutes. The, recovered to normal shortly after the incident.
He developed acute chest pain 4 days after the vaccine and presented to the ED.  Pain  was worse in recumbent position and improved with sitting.  ED physician suspected possible pericarditis and he was given ibuprofen.  Symptoms resolved within 24 houtrs while taking ibuprofen.
Rash on my left arm at the site on the injection. Pain in that spot and hot sensation. Pain in the armpit of left arm.
Adverse reaction to Dtap or IPV vaccine lg red area with swollen deltoid. Unable to determine which immunization caused reaction. Given Benadryl Per DR. Walk in clinic.
Pt received varivax 2-3 years ago pt with chicken pox today, vesicular rash all over body x 1 day positive purpurtic has eczema. Ran out of Atarax  using Benadryl, negative f/c, negative cough, good po. Atarax, oatmeal baths. Infection control.
Dime - sized to quarter - sized flat rash to bilateral forearms. OTC BENADRYL prn.
employee received vaccine 1/5/2021, presented to the ED on 1/6/2021 for c/o right side abdominal pain, fever, chills, loose stools, nausea.  Was treated for constipation and UTI, received Sulfa DS, Polyethylene glycol, naproxen.  1/20/2020 patient to PCP with patient reporting tachycardia, SOB, cough and felt horrible after receiving the COVID vaccine 2 weeks ago, woke up on 1/20/2020 with rash around both eyes, red patchy areas that are itchy and dry
7 days and 12 hours after vaccine noticed hot itchy red rash near injection site. Took Benadryl. Spoke with MD on call who did telemedicine visit and dx this as cellulitis. Already taking antibiotic which she recommended I continue as she believes it prevented more inflammation
Light headed, racing heart, numbness and tingling in arm, throat tightness, trouble swallowing.  Took 2 25mg Benadryl?s 720pm, sent home at 1030pm felt slightly better throat was still tight and scratchy.
Patient did not have an adverse event. I am reporting because MMRV and VAR were both administered at the same visit.
sore arm; warm arm; red arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (warm arm) and VACCINATION SITE ERYTHEMA (red arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 004M20A) for COVID-19 vaccination.     No Medical History Information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION SITE ERYTHEMA (red arm). 17-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warm arm). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (warm arm) and VACCINATION SITE ERYTHEMA (red arm) outcome was unknown.            No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Additional document received and contains non significant information. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 23-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (warm arm) and VACCINATION SITE ERYTHEMA (red arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 004M20A) for COVID-19 vaccination.     No Medical History Information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION SITE ERYTHEMA (red arm). 17-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warm arm). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (warm arm) and VACCINATION SITE ERYTHEMA (red arm) outcome was unknown.            No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Additional document received and contains non significant information.
Missed 2nd dose. 1st shot in June 2020; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in June 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient stated that he/she missed reminder to get 2nd Shingrix shot within 6 months, which led to incomplete course of administration. The patient further stated it was now at the time of reporting one and a half years gap and wanted to know if he/se should get the 2nd dose or start over. The patient was wondering if there was a view at Shingrix site as doctors seemed confused as per the patient because of such a long gap. The patient was notified that any information they were provided was not intended as medical advice, for medical advice he/she should refer them to his/her healthcare provider as their primary resource for patient care. The patient was disconnected twice, it was the 3rd time he/she had been there, was bumped off twice during transfer to shingrix specialist. The patient was advised- individual medical guidance for patients should be provided by medical professionals and was not something GlaxoSmithKline provides to patients. The FDA (Food and Drug Administration) approved dosing schedule for Shingrix was the first dose at month 0, followed by a second dose 2-6 months after the first dose. The Centers for Disease Control (CDC) had provided guidance that if it had been more than 6 months since a patient received the first dose, they should get the second dose as soon as possible; patients do not need to restart the vaccine series. However, the efficacy of alternative dosing regimens had not been evaluated. Data regarding the safety of alternative regimens were limited. Individuals might remain at risk for herpes zoster during a longer than recommended interval between doses 1 and 2. The patients were advised that they consult with their healthcare provider about this guidance and their individual situation. The patient stated that he/she just needed to see if there was general guidance as the gap had been long, he/she had seen the Centers for Disease Control (CDC) guidelines but imagined they meant a few months late. The patient was informed that Shingrix was administered as a 2-dose series. The FDA approved schedule did not include a booster dose of Shingrix or a repeat of the series. The patient stated he/she will figure out with the doctor and it was just that he/she was aware this was a good vaccine and wanted to be sure he/she was covered. The patient was provided with the link for the package insert. The reporter denied consent to follow up.
2 months following the vaccine, Malayah was diagnosed with intussusception.  It was reduced by air contrast enema and the infant was observed in the hospital overnight.  She has had no issues related to the intussusception since.  8/12/2008 MR received for DOS 5/23-24/2008 with D/C DX: Intussusception. 2ndary DX: Infectious enteritis. Pt presented with hx of vomiting and diarrhea and eventually a bloody stool. Initial impression: dehydration & vomiting. Air contrast enema dx and reduced the IS with no further problems.
Pain in arm starting AM after administration (couldn't lift arm") lasting thru 10/14 when pt reported. Pt took tramadol she had at home to help with pan, stated it was slowly decreasing.
Initial unsolicited report received from a consumer (patient's mother) on 22-May-2017. This case involves a 12-year-old male patient, who was vaccinated with a first dose of Adacel (Batch number, expiry date and dose were not reported) intramuscularly in right deltoid, a first dose of Menactra (Batch number, expiry date and dose were not reported) intramuscularly in left deltoid and with a dose of Gardasil (Batch number, expiry date, dose, dose in series and route of administration were not reported) in right deltoid on 28-Apr-2017. Patient's illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions were none. Concomitant medications were not reported. On 28-Apr-2017, same day following the vaccination, the patient had armpit pain and tenderness. On an unknown date, following the vaccination, the patient had developed large bump on the right arm at injection site on deltoid the size of a baseball. It was reported that on 20-May-2017, the patient showed large bump to mother which was stated by the mother was occur overnight. Laboratory investigations and corrective treatments were not reported. Patient recovered from the events armpit pain and tenderness on an unspecified date after 4 days. The patient not recovered from the event large bump on the right arm at injection site on deltoid the size of a baseball. List of the documents held by sender: none.